Correlation Between Personalis and HTG Molecular

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Personalis and HTG Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Personalis and HTG Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Personalis and HTG Molecular Diagnostics, you can compare the effects of market volatilities on Personalis and HTG Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Personalis with a short position of HTG Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Personalis and HTG Molecular.

Diversification Opportunities for Personalis and HTG Molecular

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Personalis and HTG is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Personalis and HTG Molecular Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HTG Molecular Diagnostics and Personalis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Personalis are associated (or correlated) with HTG Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HTG Molecular Diagnostics has no effect on the direction of Personalis i.e., Personalis and HTG Molecular go up and down completely randomly.

Pair Corralation between Personalis and HTG Molecular

Given the investment horizon of 90 days Personalis is expected to generate 0.57 times more return on investment than HTG Molecular. However, Personalis is 1.76 times less risky than HTG Molecular. It trades about 0.05 of its potential returns per unit of risk. HTG Molecular Diagnostics is currently generating about -0.07 per unit of risk. If you would invest  270.00  in Personalis on September 3, 2024 and sell it today you would earn a total of  127.00  from holding Personalis or generate 47.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy30.91%
ValuesDaily Returns

Personalis  vs.  HTG Molecular Diagnostics

 Performance 
       Timeline  
Personalis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Personalis has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
HTG Molecular Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HTG Molecular Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, HTG Molecular is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Personalis and HTG Molecular Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Personalis and HTG Molecular

The main advantage of trading using opposite Personalis and HTG Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Personalis position performs unexpectedly, HTG Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HTG Molecular will offset losses from the drop in HTG Molecular's long position.
The idea behind Personalis and HTG Molecular Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals